全文获取类型
收费全文 | 1805篇 |
免费 | 111篇 |
国内免费 | 20篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 41篇 |
妇产科学 | 27篇 |
基础医学 | 278篇 |
口腔科学 | 24篇 |
临床医学 | 80篇 |
内科学 | 418篇 |
皮肤病学 | 50篇 |
神经病学 | 141篇 |
特种医学 | 25篇 |
外科学 | 472篇 |
综合类 | 7篇 |
预防医学 | 23篇 |
眼科学 | 20篇 |
药学 | 86篇 |
中国医学 | 1篇 |
肿瘤学 | 239篇 |
出版年
2023年 | 18篇 |
2022年 | 19篇 |
2021年 | 41篇 |
2020年 | 31篇 |
2019年 | 38篇 |
2018年 | 58篇 |
2017年 | 49篇 |
2016年 | 49篇 |
2015年 | 63篇 |
2014年 | 81篇 |
2013年 | 74篇 |
2012年 | 101篇 |
2011年 | 129篇 |
2010年 | 69篇 |
2009年 | 56篇 |
2008年 | 110篇 |
2007年 | 107篇 |
2006年 | 104篇 |
2005年 | 99篇 |
2004年 | 104篇 |
2003年 | 80篇 |
2002年 | 58篇 |
2001年 | 16篇 |
2000年 | 11篇 |
1999年 | 36篇 |
1998年 | 22篇 |
1997年 | 25篇 |
1996年 | 21篇 |
1995年 | 13篇 |
1994年 | 16篇 |
1993年 | 16篇 |
1992年 | 26篇 |
1991年 | 28篇 |
1990年 | 19篇 |
1989年 | 16篇 |
1988年 | 13篇 |
1987年 | 16篇 |
1986年 | 14篇 |
1985年 | 13篇 |
1984年 | 8篇 |
1983年 | 9篇 |
1982年 | 6篇 |
1981年 | 6篇 |
1980年 | 5篇 |
1979年 | 6篇 |
1978年 | 4篇 |
1977年 | 4篇 |
1973年 | 5篇 |
1972年 | 4篇 |
1971年 | 3篇 |
排序方式: 共有1936条查询结果,搜索用时 656 毫秒
71.
72.
73.
Hiroshi Kawaguchi Koichi Yamada Waki Imoto Kazushi Yamairi Wataru Shibata Hiroki Namikawa Naoka Yoshii Kiyotaka Nakaie Yasuyo Okada Akiko Fujita Yoshikatsu Shinoda Yasutaka Nakamura Yukihiro Kaneko Katsuya Nagayama Hiroshi Kakeya 《Journal of infection and chemotherapy》2019,25(6):458-462
Patients with invasive fungal diseases (IFDs) generally have a high mortality rate, and resistance to antifungal drugs and the high costs associated with it have led to recent problems, necessitating the appropriate use of antifungals. To this end, we launched Antifungal Stewardship Programs (AFSPs) in our hospital. Patients who were systemically administered antifungals from January 2011 to December 2016 were enrolled this study and divided into pre-intervention and intervention groups. No significant difference was observed in defined daily doses per 1000 patient-days (23.3 ± 8.0 vs 20.4 ± 10.8, p = 0.251) between the groups. The monthly average for the days of therapy per 1000 patient-days was significantly lower in the intervention group (15.1 ± 3.1 vs 12.7 ± 4.3, p = 0.009). The cost of the antifungals reduced over the 3-year period by $260,520 (13.5%). Furthermore, a decreasing trend was observed in both the 30-day mortality (40.9% vs 30.0%, p = 0.414) and in-hospital mortality (63.6% vs 36.7%, p = 0.054) in patients with candidemia. Our results indicate that AFSPs are efficacious and cost-effective approaches. 相似文献
74.
Kazushi Yamairi Kentaro Ido Shigeki Nakamura Makoto Niki Waki Imoto Wataru Shibata Hiroki Namikawa Hiroki Fujimoto Koichi Yamada Hirohisa Nakamae Masayuki Hino Yukihiro Kaneko Yoshitsugu Miyazaki Hiroshi Kakeya 《Journal of infection and chemotherapy》2019,25(4):307-310
Aspergillus species are a major cause of life-threatening infections in immunocompromised hosts, and the most common pathogen of invasive aspergillosis is Aspergillus fumigatus. Recently, the development of molecular identification has revealed cryptic Aspergillus species, and A. felis is one such species within the Aspergillus section Fumigati reported in 2013.We describe a case of invasive pulmonary aspergillosis caused by A. felis in a 41-year-old Japanese woman diagnosed with myelodysplastic syndrome. She presented with fever 19 days after undergoing autologous peripheral blood stem cell transplantation and was clinically diagnosed with invasive pulmonary aspergillosis. Bronchoscopy and bronchoalveolar lavage were performed for definitive diagnosis. The β-tubulin genes of the mold isolated from the bronchoalveolar lavage fluid, and sequenced directly from the PCR products using a primer pair were found to have 100% homology with A. felis. We successfully treated the patient with echinocandin following careful susceptibility testing.To the best of our knowledge, this is the first published case reporting the clinical course for diagnosis and successful treatment of invasive aspergillosis by A. felis. 相似文献
75.
Yasuaki Haraguchi M.D. Atsuo Sakamoto Takasuke Yoshida Kenjiro Tanaka 《Journal of gastroenterology》1988,23(3):247-250
Gastrin releasing peptide(GRP)-like immunoreactivity in human plasma was measured using radioimmunoassay of neuromedin C (NMC)
in 83 healthy and 58 diseased subjects. In the healthy group, the mean value of fasting GRP-like immunoreactivity was 2.1±1.4
(mean±SD) pmol/L. There was a slight positive correlation between the GRP-like immunoreactivity values and aging. Postprandial
serial measurements demonstrated that GRP-like immunoreacitivity showed no response to a significant elevation of serum gastrin
concentration. The group with chronic renal failure on hemodialysis gave the highest value, 7.1+2.1 pmol/L (p<0.01). There
were no statistical differences between the healthy controls and groups with peptic ulcer, liver cirrhosis, diabetes mellitus
or carcinomas, although some cancer patients had a marked increase in GRP-like immunoreactivity value. 相似文献
76.
Major histocompatibility complex gene mapping in the amphibian Xenopus implies a primordial organization
下载免费PDF全文
![点击此处可从《Proceedings of the National Academy of Sciences of the United States of America》网站下载免费的PDF全文](/ch/ext_images/free.gif)
77.
Hidemi Kajimoto Makoto Nakazawa Kagari Murasaki Yoshiki Mori Kenjiro Tanoue Hiroshi Kasanuki Toshio Nakanishi 《Circulation journal》2007,71(6):948-953
BACKGROUND: The basic mechanisms of thromboembolism in cyanotic congenital heart disease (CCHD) have not been well clarified. P-selectin on the platelets reflects platelet activation. Thrombomodulin is a critical cofactor for thrombin-mediated activation of protein C and reflects the anticoagulant activity of the endothelium. The present study was performed to evaluate whether platelet activation exists in patients with CCHD. METHODS AND RESULTS: Platelet P-selectin as a marker of platelet activation, plasma thrombomodulin level and protein C activity as markers of anticoagulant activity of the endothelium and thrombin - antithrombin complex III (TAT) were examined in 35 patients with CCHD. Plasma thrombomodulin level (1.1+/-0.9 vs 2.2+/-0.3 FU/ml) and protein C activity (71.1+/-29.8 vs 117.8+/-24.8%) were significantly lower in patients with CCHD as compared with the control subjects. The levels of plasma TAT (255+/-811 vs 1.9+/-0.9 ng/ml) and P-selectin on platelets (6.3 +/-4.5 vs 3.3+/-0.3 mean fluorescence intensity) were significantly higher in the patients with CCHD than in the controls. Four of the CCHD patients who experienced thromboembolic events had elevated levels of platelet P-selectin (p=0.02) compared with CCHD patients without thromboembolic events. CONCLUSION: Platelet activation exists in patients with CCHD and it may play an important role in the thromboembolic events in CCHD. 相似文献
78.
Shinjoh M Sato S Sugaya N Mitamura K Takeuchi Y Kosaki K Takahashi T 《Kansenshōgaku zasshi. The Journal of the Japanese Association for Infectious Diseases》2004,78(3):262-269
During the influenza season, outbreaks of influenza may occur in the pediatric wards due to spread from the patients hospitalized with influenza, or from those hospitalized during the latency period and develop influenza afterwards. Post-exposure prophylaxis with neuraminidase inhibitors has been reported to be effective in preventing outbreaks among household members and nursing home residents. However, for nosocomial spread, its effectiveness and possible adverse effects are to be determined. During the 2002/2003 influenza season, we experienced a total of 3 nosocomial outbreaks of influenza in the pediatric wards in two hospitals in the Kanto district, Japan. Since the number of contacts who developed influenza had been increasing despite the isolation precaution implemented, post-exposure prophylaxis with oseltamivir (2 mg/kg/dose, maximum 75 mg/dose, once a day for 7-10 days) was implemented with a permission from the parents to terminate the outbreaks. In the outbreaks (one with influenza A, two with influenza B), a total of 29 inpatients had contact with influenza patients: among those 29, 13 were given post-exposure prophylaxis, 16 were not. Out of 16 patients who did not receive post-exposure prophylaxis, 11 (69%) developed influenza: out of 13 with post-exposure prophylaxis, none developed influenza. Those patients who developed influenza were given oseltamivir (2 mg/kg/dose, maximum 75 mg/dose, twice a day for 5 days) and accommodated in a private room or a room with other patients with influenza of the same type. No significant adverse effects due to oseltamivir were observed among those who were enrolled in this study. 相似文献
79.
80.